Multinational Phase News Today

Camrelizumab in Combination with Rivoceranib (Apatinib) Significantly Prolonged Overall Survival and Progression-Free Survival vs. Sorafenib in Patients with Unresectable Hepatocellular Carcinoma in a Multinational Phase 3 Trial, a Joint Program with Elevar Therapeutics

Dec 11, 2020 Malin Dunfors, Market One Media Algernon Pharmaceuticals has been hard at work repurposing Ifenprodil for those affected by idiopathic pulmonary fibrosis, chronic cough, as well as COVID-19. , Market One Media New England Journal of Medicine reports that four repurposed antiviral drugs tested in 11,330 patients hospitalized with COVID-19 showed little to no effect Decemb...